MoneyWorks4Me

Bliss GVS Pharma informs about disclosure

04 Apr 2022 Evaluate

Bliss GVS Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.65
Dr. Reddys Labs. 1178.10
Cipla 1300.00
Lupin 1954.00
Zydus Lifesciences 1120.75
View more..